Sudeep Pharma, a company in the Pharmaceuticals industry, reported revenue of ₹197 crore and net profit of ₹52 crore for the September 2026 quarter.
Sudeep Pharma (NSE: SUDEEPPHRM) closed at ₹1,191.50 on 20 Nov 2026. Its market capitalisation is ₹13,458 crore and it trades at 71.5 times earnings.
Incorporated in 1989, Sudeep Pharma Limited is a manufacturer of pharmaceutical excipients, food-grade minerals, and specialty nutrition ingredients serving over 100 countries.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.